| Stage |
I
n=19 |
II
n=36 |
III atypical
n=31 |
III classical
n=61 |
IV
n=24 |
| 2 survivors |
13 (69%) |
26 (72%) |
14 (45%) |
42 (69%) |
15 (67%) |
| 1 survivor |
5 (26%) |
6 (17%) |
15 (48%) |
14 (23%) |
9 (33%) |
| 0 survivor |
1 (5%) |
4 (11%) |
2 (7%) |
5 (8%) |
0 (0%) |
| At least 1 survivor |
18 (95%) |
32 (89%) |
29 (93%) |
56 (92%) |
24 (100%) |
| Overall survival |
31/38 (82%) |
58/72 (81%) |
43/62 (69%) |
98/122 (80%) |
39/48 (81%) |
| Neurological sequels |
1/31 (3.2%) |
4/58 (6.9%) |
3/43 (6.9%) |
2/98 (2.0%) |
3/39 (7.7%) |
Data are shown as number (%) |
